LPW-E/1.2.2/770 — KillAsthma (Q3332880): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Although asthma is one of the most common respiratory diseases with more than 235 million people worldwide, little is known about the causes and mechanisms of the disease and the diagnosis is difficult. Especially in children, early detection of the disease can decide on life and death in case of doubt. The consortium of this collaborative project pursues an innovative approach that assesses a patient’s risk of asthma through the analysis of blo...) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
LPW-E/1.2.2/770 — KillAsthma | |||
Revision as of 07:54, 25 October 2021
Project Q3332880 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LPW-E/1.2.2/770 — KillAsthma |
Project Q3332880 in Germany |
Statements
246,055.95 Euro
0 references
523,523.3 Euro
0 references
47.0 percent
0 references
1 October 2017
0 references
31 March 2021
0 references
Pattern Recognition Company GmbH
0 references
23562 Lübeck
0 references
Obwohl Asthma mit weltweit über 235 Mio Erkrankten zu den häufigsten Atemwegserkrankungen gehört, ist wenig über die Ursachen und Entstehungsmechanismen der Krankheit bekannt und die Diagnose schwierig. Gerade bei Kindern kann eine Früherkennung der Krankheit im Zweifelsfall über Leben und Tod entscheiden. Das Konsortium dieses Verbundprojektes verfolgt einen innovativen Ansatz, der über die Analyse von Blutzellen das Risiko eines Patienten einschätzt, an Asthma erkrankt zu sein. Ziel ist ein diagnostisches Verfahren, das schnell und einfach eingesetzt werden kann, um sowohl die Krankheit zu diagnostizieren, als auch die Therapie zu überwachen. (German)
0 references
Although asthma is one of the most common respiratory diseases with more than 235 million people worldwide, little is known about the causes and mechanisms of the disease and the diagnosis is difficult. Especially in children, early detection of the disease can decide on life and death in case of doubt. The consortium of this collaborative project pursues an innovative approach that assesses a patient’s risk of asthma through the analysis of blood cells. The aim is a diagnostic procedure that can be used quickly and easily to diagnose the disease and monitor therapy. (English)
25 October 2021
0 references
Identifiers
DE_TEMPORARY_35525
0 references